Institute of Biomedicine

Contact Details

Persons

  

  

  

1 of 31

  

  

  

---

• Aaltonen, Virpi
• Aatsinki, Milla
• Abbas, Hyder
• Abdelkawy, Yara
• Abe, Oluwatosin
• Abid, Tazrian
• Abouguendia, Hatem
• Abuasaker, Baraa
• Adamsson, Annika
• Afshan, Syeda
• Ahmedani, Ammar
• Ahmed, Nisar
• Ahramo, Kaisa
• Airaksinen, Jenni
• Åkerfelt, Malin
• Akram, Sadia
• Alanne, Erika
• Ali, Aliaa
• Alinikula, Jukka
• Alipour, Maedeh

Publications

  

  

  

363 of 522

  

  

  

---

• Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose  (2023)
• Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses  (2018)
• Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells  (2019)
• Personalized laboratory medicine: A patient-centered future approach  (2018)
• Personalized multifactorial risk assessment in neoadjuvant-treated breast carcinoma  (2024)
• Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015  (2019)
• Pertussis epidemic in Slovenia in 2024—no pertactin-deficient or macrolide-resistant Bordetella pertussis isolates identified  (2025)
• Pertussis Outbreak in a Primary School in China: Infection and Transmission of the Macrolide-resistant Bordetella pertussis  (2018)
• Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines  (2019)
• Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries  (2021)